Author:
Zha Wenliang,Zhao Qian,Xiao Ye,Gan Yuanyuan,Wei Junjun,Yu Mengqi,Xu Yanmei,Xu Qiongyao,Wu Shi,Yu Wei
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference51 articles.
1. G. European paediatric Soft tissue sarcoma Study, Addition of dose-intensified doxorubicin to standard chemotherapy for rhabdomyosarcoma (EpSSG RMS 2005): a multicentre, open-label, randomised controlled, phase 3 trial;Bisogno;LancetOncol,2018
2. Targeting the PI3K/AKT/mTOR pathway for the treatment of mesenchymal triple-negative breast cancer: evidence from a phase 1 trial of mTOR inhibition in combination with liposomal doxorubicin and bevacizumab;Basho;JAMAOncol,2017
3. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia;Kantarjian;J Clin Oncol,1990
4. The effect of dexrazoxane on myocardial injury in doxorubicin-treated children with acute lymphoblastic leukemia;Lipshultz;N Engl J Med,2004
5. Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia;Lipshultz;J Clin Oncol,2005
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献